Top Markets
Coin of the day
Celadon Pharmaceuticals Plc Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc

CEL
Rang in aandelen #40708
Celadon Pharmaceuticals Plc functions as a drug development company,... Celadon Pharmaceuticals Plc functions as a drug development company, concentrating on the discovery, production, and distribution of cannabinoid compounds for certified medical uses. The firm's primary activity involves the indoor, hydroponic cultivation of THC cannabis, which is then incorporated into medicinal products targeting chronic pain. Furthermore, Celadon intends to broaden its research into cannabinoids, exploring their therapeutic applications not only for persistent pain but also for conditions such as autism and multiple sclerosis. Established in 2018, the company maintains its headquarters in London, United Kingdom.
Aandeelprijs
$0.00179028
Laatst gesynchroniseerd: 2025-07-28
Marktkapitalisatie
$94.61K
Verandering (1 dag)
-0.54%
Verandering (1 jaar)
0.00%
Land
GB
Handel Celadon Pharmaceuticals Plc (CEL)

Categorie

Dividendrendementgeschiedenis voor Celadon Pharmaceuticals Plc (CEL)
Het dividendrendement (TTM) van Celadon Pharmaceuticals Plc (aandelsymbool: CEL) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Celadon Pharmaceuticals Plc (CEL) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten